ARTICLE
|
doi:10.20944/preprints202409.0945.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Pancreatic cancer; MUC5AC; biomarker; predicting; pancreatic ductal adenocarcinoma, neoadjuvant therapy; treatment response; FOLFIRINOX
Online: 12 September 2024 (13:19:57 CEST)